Target
Alpha-synuclein
Ligand
BDBM50085536
Substrate
n/a
Meas. Tech.
ChEMBL_1991810 (CHEMBL4625545)
IC50
4430±n/a nM
Citation
 Chen, LHuang, GLLü, MHZhang, YXXu, JBai, SP Amide derivatives of Gallic acid: Design, synthesis and evaluation of inhibitory activities against in vitro ?-synuclein aggregation. Bioorg Med Chem 28:0 (2020) [PubMed]  Article 
Target
Name:
Alpha-synuclein
Synonyms:
NACP | PARK1 | SNCA | SYUA_HUMAN
Type:
Protein
Mol. Mass.:
14451.42
Organism:
Homo sapiens (Human)
Description:
P37840
Residue:
140
Sequence:
MDVFMKGLSKAKEGVVAAAEKTKQGVAEAAGKTKEGVLYVGSKTKEGVVHGVATVAEKTKEQVTNVGGAVVTGVTAVAQKTVEGAGSIAAATGFVKKDQLGKNEEGAPQEGILEDMPVDPDNEAYEMPSEEGYQDYEPEA
  
Inhibitor
Name:
BDBM50085536
Synonyms:
3,4,5-Trihydroxybenzoate, X | 3,4,5-trihydroxybenzoic acid | CHEMBL288114 | Gallic Acid, F | gallic acid
Type:
Small organic molecule
Emp. Form.:
C7H6O5
Mol. Mass.:
170.1195
SMILES:
OC(=O)c1cc(O)c(O)c(O)c1
Structure:
Search PDB for entries with ligand similarity: